2016
DOI: 10.1177/2042098616641355
|View full text |Cite
|
Sign up to set email alerts
|

Factors associated with antidepressant use in residents with and without dementia in Australian aged care facilities

Abstract: The prevalence of antidepressant use was similar in residents with and without dementia. Clinician-observed pain was inversely associated with antidepressant use but there was no association between self-reported pain and antidepressant use.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 42 publications
0
5
0
Order By: Relevance
“…than encouraging individualized assessments of the benefit and risk of continuing or discontinuing FRIDs based on each resident's current clinical indications (Hiltunen et al, 2016;Nguyen et al, 2012). Assessing the benefits and risks of FRIDs is dependent on access to high-quality evidence on medication safety and effectiveness in the residential aged care setting, including among people with dementia.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…than encouraging individualized assessments of the benefit and risk of continuing or discontinuing FRIDs based on each resident's current clinical indications (Hiltunen et al, 2016;Nguyen et al, 2012). Assessing the benefits and risks of FRIDs is dependent on access to high-quality evidence on medication safety and effectiveness in the residential aged care setting, including among people with dementia.…”
Section: Discussionmentioning
confidence: 99%
“…Most residents using antidepressants and renin–angiotensin system inhibitors had a documented diagnosis of depression and hypertension, respectively. This suggests that generic initiatives to reduce medication-related falls based on simple avoidance of FRIDs may be less successful than encouraging individualized assessments of the benefit and risk of continuing or discontinuing FRIDs based on each resident’s current clinical indications (Hiltunen et al, 2016; Nguyen et al, 2012). Assessing the benefits and risks of FRIDs is dependent on access to high-quality evidence on medication safety and effectiveness in the residential aged care setting, including among people with dementia.…”
Section: Discussionmentioning
confidence: 99%
“…There was a major change in the pattern of prescribing in aged care homes from the late 1990s, when TCAs, particularly amitriptyline and nortriptyline, were largely replaced by SSRIs, especially sertraline, citalopram and escitalopram. The latter became the most frequently used antidepressants in aged care homes in most countries, including Belgium [6,27,51], Finland [14], Norway [10,52,53], Sweden [54,55,56,57], Austria [15], Slovenia [42], US [37,58,59], and Singapore [60], as well as ANZ [61,62,63,64]. However, mirtazapine, which is an atypical antidepressant, was most frequently prescribed in other studies conducted in the US and Sweden [17,39].…”
Section: Discussionmentioning
confidence: 99%
“…Over the years, there has been an increase in use of antidepressant in NH [ 3 ], especially among residents with dementia or cognitive impairment [ 4 ]. In NH, misconducts in medication therapy may represent a potential risk of adverse drug reactions and accidental poisonings [ 5 ].…”
Section: Introductionmentioning
confidence: 99%